Ning Ma

Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma

Ann‐Lii Cheng, Shukui Qin, Masafumi Ikeda et al. · Journal of Hepatology · 2021 · 1.5K citations · Full text

Hepatology, Atezolizumab Plus Bevacizumab, Unresectable Hepatocellular Carcinoma +9

KCNQ1 Gain-of-Function Mutation in Familial Atrial Fibrillation

Yi-Han Chen, Shi-Jie Xu, Saı̈d Bendahhou et al. · Science · 2003 · 990 citations

Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients

Bao‐Dong Qin, Ning Ma, Qingqin Tang et al. · Modern Rheumatology · 2015 · 440 citations

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

Concentrations and health risks of lead, cadmium, arsenic, and mercury in rice and edible mushrooms in China

Yong Fang, Xinyang Sun, Wenjian Yang et al. · Food Chemistry · 2013 · 266 citations

Environmental Chemistry, Engineering, Environmental Engineering +14